Photo taken from Caroline J Loew/LinkedIn
Nov 17, 2023, 16:24
Caroline J Loew: We’re excited to launch Mural Oncology
Caroline J Loew, CEO of Mural Oncology, shared
“We’re excited to launch Mural Oncology today! Mural is a clinical stage immuno-oncology company committed to delivering the next generation of IO treatments to patients, starting with our lead asset, nemvaleukin that is in two registrational studies.
We’re looking forward to sharing our story and data as we reach key milestones, both on nemvaleukin and our preclinical pipeline. Stay tuned!
Want to learn more about Mural? Go to this page.”
Sources: Caroline J Loew/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 21, 2025, 20:46
Apr 21, 2025, 20:30
Apr 21, 2025, 20:11
Apr 21, 2025, 19:55
Apr 21, 2025, 19:12
Apr 21, 2025, 18:19
Apr 21, 2025, 18:00
Apr 21, 2025, 17:40
Apr 21, 2025, 17:35
Apr 21, 2025, 17:29